ALEC: the balance sheet

MyFinsight

For the quarter ending 2026-03-31, ALEC has $239,916K in assets. $229,534K in debts. $76,962K in cash and cash equivalents.

Balance Sheets Overview

Current Ratio
525.04%
Quick Ratio
525.04%
Cash Ratio
187.87%
Debt to Asset Ratio
95.67%
Unit: Thousand (K) dollars
Assets Breakdown
Marketable securities
Cash and cash equivalents
Operating lease right-of-use ass...
Others
Liabilities Breakdown
Additional paid-in capital
Accumulated deficit
Deferred revenue, long-term port...
Others

Balance Sheets	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Cash and cash equivalents	76,962	65,802	76,503	44,771
Marketable securities	129,553	190,222	214,605	262,509
Prepaid expenses and other current assets	8,569	10,428	9,277	11,898
Total current assets	215,084	266,452	300,385	319,178
Property and equipment, gross	-	48,334	-	-
Less accumulated depreciation and amortization	-	37,493	-	-
Property and equipment, net	9,934	10,841	12,714	13,914
Operating lease right-of-use assets	12,683	13,712	15,869	16,990
Restricted cash	1,846	1,846	1,846	1,846
Other assets	369	386	4,471	4,494
Total assets	239,916	293,237	335,285	356,422

Accounts payable	1,423	1,691	4,757	2,217
Accrued clinical supply costs	1,044	3,669	3,547	5,150
Accrued liabilities	10,931	19,299	18,332	14,215
Deferred revenue, current portion	6,723	6,684	11,743	13,402
Payable to collaboration partner	10,229	17,289	10,788	6,607
Refund liability to collaboration partner, current portion	0	11,449	21,818	33,859
Operating lease liabilities, current portion	9,135	9,056	8,979	8,904
Short-term debt	1,480	366	-	-
Refund liability to collaboration partner, long-term portion	-	0	0	0
Total current liabilities	40,965	69,503	79,964	84,354
Deferred revenue, long-term portion	162,866	164,537	167,269	168,870
Long-term debt	8,287	9,323	9,611	9,536
Operating lease liabilities, long-term portion	15,646	17,488	19,285	21,043
Other long-term liabilities	1,770	1,737	1,444	1,444
Total liabilities	229,534	262,588	277,573	285,247
Common stock, 0.0001 par value 200,000,000 shares authorized 111,025,187 and 110,362,581 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively	11	11	10	9
Additional paid-in capital	1,005,461	1,002,528	992,294	971,192
Accumulated other comprehensive income (loss)	-104	166	197	96
Accumulated deficit	-994,986	-972,056	-934,789	-900,122
Total stockholders' equity	10,382	30,649	57,712	71,175
Total liabilities and stockholders equity	239,916	293,237	335,285	356,422

Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

MyFinsight

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Balance Sheets Overview

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets